Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Adenoid Cystic × Cetuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 39 Carcinoma, Non-Small-Cell Lung 21 Squamous Cell Carcinoma of Head and Neck 19 Pancreatic Neoplasms 11 Head and Neck Neoplasms 11 Colonic Neoplasms 7 Rectal Neoplasms 6 Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Carcinoma, Squamous Cell 6 Esophageal Neoplasms 5 Carcinoma 5 Recurrence 4 Carcinoma, Renal Cell 4 Stomach Neoplasms 3 Neoplasms, Squamous Cell 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Colorectal Cancer Metastatic 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Oligodendroglioma 2 Hereditary Sensory and Autonomic Neuropathies 2 Glioma 2 Endometrial Neoplasms 2 Diffuse Intrinsic Pontine Glioma 2 Biliary Tract Neoplasms 2 Astrocytoma 2

Interventions

pembrolizumab 1 Tablets 1 Combined Modality Therapy 1 Cetuximab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01192087 2013-04-24

ACCEPT

Heidelberg University

Phase 1/2 Unknown

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡